Who is sponsoring NCT07405892?

NCT07405892 is sponsored by National Taiwan University Hospital.

What drugs are being tested in NCT07405892?

Interventions in NCT07405892: HPI, HPI silence.

What condition does NCT07405892 study?

NCT07405892 studies the Severity and Duration of Intraoperative Hypotension.

Is NCT07405892 still recruiting?

NCT07405892 is currently not yet recruiting. Last updated 12 February 2026.

Last reviewed 2026-02-12 · How we verify

NCT07405892

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Applying HPI in Oral Cancer Surgery

Not yet recruiting NA Last updated 12 February 2026

What this trial tests

NA trial testing HPI in the Severity and Duration of Intraoperative Hypotension in 100 participants. Not yet recruiting.

Timeline

15 February 2026

Primary endpoint
31 December 2031

31 January 2032

Quick facts

Lead sponsor	National Taiwan University Hospital
Phase	NA
Status	Not yet recruiting
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	other
Enrollment	100
Start date	15 February 2026
Primary completion	31 December 2031
Estimated completion	31 January 2032

Drugs / interventions tested

HPI
HPI silence

Conditions studied

the Severity and Duration of Intraoperative Hypotension — all drugs for the Severity and Duration of Intraoperative Hypotension →

Sponsor

National Taiwan University Hospital

Who can join

Adults 20 to 80, any sex, with the Severity and Duration of Intraoperative Hypotension. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Investigating HPI effect in oral cancer surgery

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of HPI

Trials testing the same drug.

NCT06871150 — Three Different GHDT ( Goal Hemodynamic Directed Therapy) Strategies for Intraoperative Fluid Management Optimization Du · NA · recruiting
NCT05481047 — Prevention or Treatment of Arterial Hypotension and Oxygen Cerebral Saturation During Major Abdominal Surgery · NA · completed

Other National Taiwan University Hospital trials

Trials by the same sponsor.

NCT06936917 — Timing for Computed Tomography and Post-Resuscitation Care on Short-Term Outcomes in Out-of-Hospital Cardiac Arrest · not yet recruiting
NCT05396222 — A Prospective Study of the Safety and Efficacy of 3D-printed Non-rigid Biomimetic Implant in Cervical and Thoracolumbar · NA · not yet recruiting
NCT07532356 — Integrating Tumor Genomics and Urinary Exosomal Proteomics to Establish a Multi-Layer Biomarker Framework for Early Risk · not yet recruiting
NCT07317310 — The NTU JO-SMART Study · NA · not yet recruiting
NCT07382024 — Tirzepatide to Reduce rEcurrence And Burden After Ablation of Atrial Fibrillation · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT07405892 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by National Taiwan University Hospital
Last refreshed: 12 February 2026

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07405892.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing